Can Big Data bring huge R&D savings for Big Pharma?

03/13/2014 | Medill Reports (Northwestern University)

A McKinsey & Co. study found that drugmakers can cut their research and development costs by $40 billion to $70 billion with the help of Big Data. Large drugmakers can tap into various data sources, including thousands of online patient communities, more than 200 cancer support groups and more than 2,000 condition groups. Finding scientists who understand both pharmaceuticals and data mining is a major challenge.

View Full Article in:

Medill Reports (Northwestern University)

Published in Briefs: